Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Breast Cancer

Free Subscription Articles published in BMJ Retrieve available abstracts of 26 articles: HTML format

Single Articles

December 2025
1. PETRELLI F
   Adjuvant carboplatin for high risk triple negative breast cancer.
   BMJ. 2025;391:r2669.
   PubMed    
   
   
   
2. LIU Y, Gong Y, Zhu XZ, Liu GY, et al
   Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial.
   BMJ. 2025;391:e085457.
   PubMed     Abstract available
   
   
   
3. NICKEL B, Ormiston-Smith N, Cvejic E, Isautier J, et al
   Impact of population based breast density notification: multisite parallel arm randomised controlled trial in BreastScreen.
   BMJ. 2025;391:e083649.
   PubMed     Abstract available
   
   
   
4. DYER C
   Breast cancer failings: "Culture of complacency" led to unnecessary surgery and delayed treatment at NHS trust.
   BMJ. 2025;391:r2527.
   PubMed    
   
   
   November 2025
5. 
   EXPRESSION OF CONCERN: First mammography screening participation and breast cancer incidence and mortality in the subsequent 25 years: population based cohort study.
   BMJ. 2025;391:r2394.
   PubMed    
   
   
   September 2025
6. MA Z, He W, Zhang Y, Mao X, et al
   First mammography screening participation and breast cancer incidence and mortality in the subsequent 25 years: population based cohort study.
   BMJ. 2025;390:e085029.
   PubMed     Abstract available
   
   
   
7. XIA Y, Zhu Y, Ling L, Xu F, et al
   Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trial.
   BMJ. 2025;390:e084290.
   PubMed     Abstract available
   
   
   August 2025
8. SANCHEZ MJ, Petrova D
   Second primary cancers in breast cancer survivors.
   BMJ. 2025;390:r1798.
   PubMed    
   
   
   
9. BOWIE K
   Risk of second cancer after early breast cancer is low, study finds.
   BMJ. 2025;390:r1819.
   PubMed    
   
   
   
10. MACKENZIE M, Stobart H, Dodwell D, Taylor C, et al
    Patients need information on the risk of second cancer after early breast cancer.
    BMJ. 2025;390:r1584.
    PubMed    
    
    
    
11. MCGALE P, Dodwell D, Challenger A, Cutter D, et al
    Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study.
    BMJ. 2025;390:e083975.
    PubMed     Abstract available
    
    
    July 2025
12. RYSER MD, Thomas SM, Li Y, Lynch T, et al
    Cancer outcomes in women without upfront surgery for ductal carcinoma in situ: observational cohort study.
    BMJ. 2025;390:e083542.
    PubMed     Abstract available
    
    
    April 2025
13. O'DOWD A
    NICE recommends "targeted" drug capivasertib for advanced breast cancer.
    BMJ. 2025;389:r762.
    PubMed    
    
    
    December 2024
14. PARK B, Chang Y, Ryu S, Tran TXM, et al
    Trajectories of breast density change over time and subsequent breast cancer risk: longitudinal study.
    BMJ. 2024;387:e079575.
    PubMed     Abstract available
    
    
    
15. ROBINSON A
    Advances in breast cancer and bowel cancer treatments ... and other research.
    BMJ. 2024;387:q2699.
    PubMed    
    
    
    October 2024
16. HE M, Jiang YZ, Gong Y, Fan L, et al
    Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial.
    BMJ. 2024;387:e079603.
    PubMed     Abstract available
    
    
    
17. MASON S
    Risk prediction in early triple negative breast cancer.
    BMJ. 2024;387:q2088.
    PubMed    
    
    
    
18. TANNE JH
    Breast cancer: Cases rising among younger US women although deaths are dropping.
    BMJ. 2024;387:q2199.
    PubMed    
    
    
    September 2024
19. TANNE JH
    US women must be told breast density after mammogram, says FDA.
    BMJ. 2024;386:q2045.
    PubMed    
    
    
    
20. LEE SF, Kennedy SKF, Caini S, Wong HCY, et al
    Randomised controlled trials on radiation dose fractionation in breast cancer: systematic review and meta-analysis with emphasis on side effects and cosmesis.
    BMJ. 2024;386:e079089.
    PubMed     Abstract available
    
    
    August 2024
21. BAUM M
    Breast cancer screening does not improve length or quality of life.
    BMJ. 2024;386:q1752.
    PubMed    
    
    
    
22. AUTIER P
    Breast cancer screening expansion: modelling doesn't reflect real life and should not be used to update guidance.
    BMJ. 2024;386:q1750.
    PubMed    
    
    
    July 2024
23. RIMMER A
    Navigating breastfeeding through cancer treatment.
    BMJ. 2024;386:q1284.
    PubMed    
    
    
    June 2024
24. BELL KJ, Nickel B, Pathirana T, Blennerhassett M, et al
    Breast cancer screening from age 40 in the US.
    BMJ. 2024;385:q1353.
    PubMed    
    
    
    May 2024
25. TANNE JH
    US expert panel says breast cancer screening should begin at 40.
    BMJ. 2024;385:q1020.
    PubMed    
    
    
    April 2024
26. WISE J
    Breast cancer: Inaction on inequalities has led to unequal progress, say experts.
    BMJ. 2024;385:q854.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.